A 0.8-kilobase SaI DNA fragment in the distal 5'-noncoding region of the c-Ha-rasl oncogene hybridized to high guanine * cytosine sites of herpes simplex virus type 1 (HSV-1) DNA restriction fragments. Nucleotide sequence comparisons localized one of these sites to the intergenic region of HSV between the immediate-early genes coding for IEmRNA-3 and IEmRNA-4/5 that has enhancer-type activity. We tested the possibility that the HSV-1 enhancer and the upstream c-Ha-rasl SacI fragment were functionally related by assaying for the capacity of recombinant plasmids in which the HSV-1 enhancer replaced the oncogene 0.8-kilobase SacI fragment to transform NIH/3T3 cells. Deletion of the 0.8-kilobase Sacl fragment abolished the biological activity of c-Ha-rasl, but its replacement by the HSV-1 enhancer fully restored it. These results confirm the enhancer properties of the HSV-1 immediate-early intergenic region and suggest that c-Ha-rasl sequences contained within the 0.8-kilobase SacI fragment plays a role in the transcriptional activation of the oncogene.
Regions of the genome of several herpesviruses have been found to be related to an evolutionarily conserved family of mammalian DNA (8, 14, 15) . In preliminary experiments designed to investigate whether these regions of homology involved known oncogenes, we tested several 32P-labeled cloned oncogene probes for their ability to hybridize to Southern blots of EcoRI DNA fragments of herpes simplex virus type 1 (HSV-1) strain F. We observed that one of the probes, c-Ha-rasl, efficiently hybridized to DNA fragments derived from the terminal and internal repetitions of the viral genome. When we used two different SacI fragments of the c-Ha-rasl oncogene, hybridization was limited to the 0.8-kilobase (kb) SacI fragment containing distal 5'-noncoding oncogene sequences. This fragment is not present in the transforming genes of BALB and Harvey murine sarcoma virus, but only in the oncogene obtained from the T24 human bladder carcinoma cell line and, with one deletion of six nucleotides, in the nontransforming proto-oncogene (2, 18) .
We mapped the sites that hybridized to oncogene sequences by using cloned BamHI fragments of HSV-1 DNA that span the entire inverted repeat region of the viral genome (data not shown). In addition, we used the SEQ algorithm (1) to compare published nucleotide sequences of c-Ha-rasl (2, 18) and HSV-1 (5, 10, 11-13, 23). We found over 100 stretches of base pair matches between HSV-1 DNA sequences and the 0.8-kb SacI fragment of c-Ha-rasl. These matches almost always involved guanine -cytosinerich regions and extended over not more than 40 to 60 nucleotide residues. (10, 13, 20, 23) . This region is involved in transcriptional control, since it contains positive regulatory sequence elements (4, 9, 10, 24) functionally similar to the transcriptional enhancers identified in other eucaryotic viruses and in the human, monkey, and murine genomes (3, 17, 21) . Sites of relatedness to the oncogene 0.8-kb Sacd fragment occur in guanine * cytosine tracts within a 224-base-pair EcoRI-SmaI fragment which has been shown recently to have enhancertype activity (9) . Since undetermined 5'-flanking regions of the oncogene may play a regulatory role in gene expression (2, 18), our observations led us to speculate that the HSV-1 enhancer and the c-Ha-rasl Sacd fragment might contain related regulatory signals. If this were the case, the HSV-1 enhancer and the Sacd fragment might be mutually interchangeable. Deletion of the region of c-Ha-rasl involved in the homology, or digestion of the oncogene with SacI, markedly reduces its transforming activity (16, 18) ; therefore, it was feasible to determine whether the HSV enhancer fragment could replace its related oncogene fragment in transformation assays. Recombinant plasmid chimeras were constructed that contained the 224-base-pair EcoRI-SmaI enhancer fragment from HSV-1 DNA joined in all four possible orientations to the ca. 3-kb Sacd fragment of c-Ha-rasl that contains the TATA box and the sequences coding for the p21 protein. First, the 224-base-pair enhancer fragment was subcloned by digestion of plasmid pKL43 (6) with SmaI, ligation of BamHI linkers, and recircularization. This resulted in plasmid pJGEn3, which has the SmaI site converted to a BamHI site. The ca. 3-kb SacI fragment of the transforming oncogene was obtained from plasmid pT24-C3, and its nontransforming homolog was from pbc-N1 (19, 22 on September 29, 2017 by guest http://jvi.asm.org/ Downloaded from fragment was ligated onto the newly created SacI sites. A similar procedure was used for the BamHI site of pJGEn3 to construct the remaining four chimeras pTB-5', pNB-5', pTB-3', and pNB-3'. The relative orientations of enhancer and c-Ha-rasl-coding sequences were determined by digestion with appropriate restriction enzymes. Before their use in transformation, the derivation of the 3-kb Sacl fragment (oncogene or normal homolog) was reconfirmed by digestion with NaeI, diagnostic for the oncogene mutation (19) . The transforming activity of the chimeras constructed was then determined by transfection onto NIH/3T3 cells. The results of these experiments are presented in Fig. 2 . The controls show that the HSV-1 enhancer in pJGEn3 has no transforming capacity, whereas the complete 6.6-kb oncogene in pT24-C3 transforms readily, unlike its nontransforming homolog, pbc-N1. The oncogene coding sequences contained in the 3-kb SacI2-SacI3 fragment in pTRA have almost no transforming activity, in agreement with previous reports (16, 18) . In contrast, replacement of the 0.8-kb fragment between SacIl and SacI2 by the HSV-1 224-basepair enhancer fragment fully restores the transforming capacity of the oncogene. This effect is independent of the orientation (5' or 3') and position (up or downstream) at which the enhancer is inserted. None of the constructs with the normal homolog of c-Ha-rasl has transforming activity.
It has been postulated that the region of c-Ha-rasl upstream from the TATA box might have a regulatory function in gene expression (2, 18) , although the nature of this function has not been ascertained. Our results demonstrate that this region plays an essential transcriptional regulatory role, since its deletion abolishes transformation activity which can be restored by an HSV-1 enhancer. Consequently, it is likely that this function may be that of a transcriptional activator element.
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